AG
HSTO

Advisor Group’s Histogen Inc. Common Stock HSTO Stock Holding History

Advisor Group’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$0 Hold
5
– – ﹤0.01% 5523
2019
Q3 		$0 Hold
5
– – ﹤0.01% 5504
2019
Q2 		$0 Hold
5
– – ﹤0.01% 5436
2019
Q1 		$1K Hold
5
– – ﹤0.01% 5148
2018
Q4 		$2K Hold
5
– – ﹤0.01% 4872
2018
Q3 		$6K Buy
+5
New +$4.61K ﹤0.01% 4547
2018
Q1 		– Sell
-5
Closed -$5K – 5127
2017
Q4 		$5K Buy
5
+2
+67% +$1.85K ﹤0.01% 4436
2017
Q3 		$4K Buy
+3
New +$3.41K ﹤0.01% 4379

Other funds holding HSTO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Advisor Group's HSTO Position: Q4 2019 in Review

Advisor Group held its Histogen Inc. Common Stock (HSTO) position steady in Q4 2019 at 5 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5523.

Advisor Group first reported a position in HSTO in Q3 2017 and has held it in 8 quarters since. The position peaked at $6K in Q3 2018. 28 funds tracked by Wall St. Rank hold HSTO as of Q4 2019.

  • Advisor Group held 5 shares of Histogen Inc. Common Stock worth $0 as of Q4 2019.
  • Advisor Group left its Histogen Inc. Common Stock share count unchanged in Q4 2019.
  • Histogen Inc. Common Stock made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5523 holding.
  • Advisor Group first reported a position in Histogen Inc. Common Stock in Q3 2017 and has held it in 8 quarters since.
  • Advisor Group's Histogen Inc. Common Stock position peaked at $6K in Q3 2018.
  • 28 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.